Inspiratory muscle training in children and adolescents living with neuromuscular diseases: A pre-experimental study.

children inspiratory muscle strength inspiratory muscle training neuromuscular disease pulmonary function

Journal

The South African journal of physiotherapy

ISSN: 2410-8219

Titre abrégé: S Afr J Physiother

Pays: South Africa

ID NLM: 9816433

Informations de publication

Date de publication:
2021

Historique:

received: 23 03 2021

accepted: 28 06 2021

entrez: 15 9 2021

pubmed: 16 9 2021

medline: 16 9 2021

Statut: epublish

Résumé

Children with neuromuscular diseases (NMD) are at risk of morbidity and mortality because of progressive respiratory muscle weakness and ineffective cough. Inspiratory muscle training (IMT) aims to preserve or improve respiratory muscle strength, thereby reducing morbidity and improving health-related quality of life (HRQoL). To describe the safety and feasibility of a 6-week IMT programme using an electronic threshold device (Powerbreathe®). Any adverse events and changes in functional ability, spirometry, peak expiratory cough flow (PECF), inspiratory muscle strength and HRQoL (Pediatric Quality of Life [PedsQL]) were recorded. A convenience sample of eight participants ( There were significant pre- to post-intervention improvements in upper limb function and coordination ( Inspiratory muscle training (at an intensity of 30% Pimax) appears safe, feasible and acceptable, in a small sample of children and adolescents with NMD and was associated with improved inspiratory muscle strength, PIF and upper limb function and coordination. Larger, longer-term randomised controlled trials are warranted to confirm the safety and efficacy of IMT as an adjunct respiratory management strategy in children with NMD.

Sections du résumé

BACKGROUND BACKGROUND

OBJECTIVES OBJECTIVE

To describe the safety and feasibility of a 6-week IMT programme using an electronic threshold device (Powerbreathe®). Any adverse events and changes in functional ability, spirometry, peak expiratory cough flow (PECF), inspiratory muscle strength and HRQoL (Pediatric Quality of Life [PedsQL]) were recorded.

METHODS METHODS

A convenience sample of eight participants (

RESULTS RESULTS

There were significant pre- to post-intervention improvements in upper limb function and coordination (

CONCLUSION CONCLUSIONS

Inspiratory muscle training (at an intensity of 30% Pimax) appears safe, feasible and acceptable, in a small sample of children and adolescents with NMD and was associated with improved inspiratory muscle strength, PIF and upper limb function and coordination.

CLINICAL IMPLICATIONS CONCLUSIONS

Larger, longer-term randomised controlled trials are warranted to confirm the safety and efficacy of IMT as an adjunct respiratory management strategy in children with NMD.

Identifiants

DOI: 10.4102/sajp.v77i1.1577 PMID: 34522820 PMC: PMC8424756

pubmed: 34522820

doi: 10.4102/sajp.v77i1.1577

pii: SAJP-77-1577

pmc: PMC8424756

doi:

Types de publication

Journal Article

Langues

eng

Pagination

1577

Informations de copyright

Déclaration de conflit d'intérêts

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

Références

Arch Bronconeumol. 2013 Jul;49(7):306-13

pubmed: 23410743

Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13818-23

pubmed: 11087833

Yonsei Med J. 2010 May;51(3):392-7

pubmed: 20376892

Clin Investig (Lond). 2011 Sep;1(9):1217-1235

pubmed: 22639722

Neuromuscul Disord. 2002 Aug;12(6):576-83

pubmed: 12117483

Thorax. 2012 Jul;67 Suppl 1:i1-40

pubmed: 22730428

Clin Rehabil. 2008 Aug;22(8):741-8

pubmed: 18678574

Pediatr Pulmonol. 2000 Feb;29(2):141-50

pubmed: 10639205

Am J Respir Crit Care Med. 2004 Aug 15;170(4):456-65

pubmed: 15302625

Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1507-11

pubmed: 11029369

Kaohsiung J Med Sci. 2009 Jun;25(6):325-33

pubmed: 19560997

Chest. 2001 Sep;120(3):765-9

pubmed: 11555507

Med Care. 2001 Aug;39(8):800-12

pubmed: 11468499

J Bras Pneumol. 2014 Oct;40(5):528-34

pubmed: 25410841

Neuromuscul Disord. 2009 Dec;19(12):805-12

pubmed: 19846309

Med Sci Sports Exerc. 1999 Nov;31(11):1522-7

pubmed: 10589852

J Physiol. 2014 Nov 1;592(21):4627-38

pubmed: 25194047

Dev Med Child Neurol. 2012 Oct;54(10):879-85

pubmed: 22713125

Respir Care. 2006 Aug;51(8):829-37; discussion 837-9

pubmed: 16929568

Muscle Nerve. 2000 Aug;23(8):1257-60

pubmed: 10918264

S Afr J Physiother. 2021 May 07;77(1):1527

pubmed: 34131595

Am J Phys Med Rehabil. 2008 Jun;87(6):461-7

pubmed: 18496248

Eur Respir J. 2002 Sep;20(3):570-6

pubmed: 12358330

Cochrane Database Syst Rev. 2019 Sep 05;9:CD011711

pubmed: 31487757

Clin Rehabil. 2014 Jun;28(6):573-81

pubmed: 24275453

Ann Am Thorac Soc. 2019 Apr;16(4):478-487

pubmed: 30562038

Lancet Neurol. 2018 Apr;17(4):347-361

pubmed: 29395990

Children (Basel). 2018 Jun 15;5(6):

pubmed: 29914128

Eur Respir J. 2005 Aug;26(2):319-38

pubmed: 16055882

Arch Phys Med Rehabil. 2010 Sep;91(9):1466-70

pubmed: 20801269

Respir Med. 2018 Mar;136:98-110

pubmed: 29501255

Curr Opin Neurol. 2017 Oct;30(5):529-537

pubmed: 28562381

Neuromuscul Disord. 2017 Apr;27(4):307-314

pubmed: 28189481

Neuromuscul Disord. 2017 Jun;27(6):503-517

pubmed: 28462787

J Bras Pneumol. 2015 Mar-Apr;41(2):110-23

pubmed: 25972965

J Neuromuscul Dis. 2018;5(1):47-58

pubmed: 29278896

Chest. 1994 Feb;105(2):475-82

pubmed: 8306750

Neuromuscul Disord. 2018 Mar;28(3):289-298

pubmed: 29395673

Pediatr Pulmonol. 2002 Jul;34(1):42-6

pubmed: 12112796

Neuromuscul Disord. 2002 Dec;12(10):975-83

pubmed: 12467755

Phys Ther. 1995 Nov;75(11):1006-14

pubmed: 7480122

Am J Respir Crit Care Med. 2006 Jul 1;174(1):67-74

pubmed: 16574932

Eur Respir J. 2003 Mar;21(3):502-8

pubmed: 12662009

Paediatr Respir Rev. 2007 Mar;8(1):90-3

pubmed: 17419983

S Afr J Physiother. 2019 Jun 25;75(1):1295

pubmed: 31309166

Chron Respir Dis. 2009;6(4):231-49

pubmed: 19858353